Treatment of Type II Endoleaks with Onyx

Endoleaks are defined as persistent perfusion of an abdominal aortic aneurysm (AAA) after endovascular stent-graft deployment. The authors describe their experience treating six endoleaks with the liquid embolic agent Onyx (ethylene-vinyl-alcohol copolymer). Complete endoleak occlusion was achieved...

Full description

Saved in:
Bibliographic Details
Published inJournal of vascular and interventional radiology Vol. 12; no. 5; pp. 629 - 632
Main Authors Martin, Michael L., Dolmatch, Bart L., Fry, Peter D., Machan, Lindsay S.
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 01.05.2001
Subjects
Aged
Aged, 80 and over
Aneurysm, aortic
Aorta, grafts and prostheses
Aortic Aneurysm, Abdominal - surgery
Embolization, Therapeutic - methods
Endoleak
Female
Follow-Up Studies
Humans
Male
Polyvinyls - therapeutic use
Postoperative Complications
Stents and prostheses
Stents and prostheses
AAA
DMSO
Endoleak
Aneurysm, aortic
IMA
Aorta, grafts and prostheses
Online AccessGet full text

Cover

More Information
Summary:Endoleaks are defined as persistent perfusion of an abdominal aortic aneurysm (AAA) after endovascular stent-graft deployment. The authors describe their experience treating six endoleaks with the liquid embolic agent Onyx (ethylene-vinyl-alcohol copolymer). Complete endoleak occlusion was achieved in five of six cases. Follow-up imaging has demonstrated decreased aneurysm diameter in all patients 7–29 weeks (mean = 19.2 weeks) after treatment.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1051-0443
1535-7732
DOI:10.1016/S1051-0443(07)61489-4